Sponsored Webinar: Improving Sepsis Diagnosis and Management with Precision Medicine Tools
Sponsored by Immunexpress
In this sponsored webinar, Kenneth Remy, MD, MHSc, MSCI, FCCM, will speak to the current challenges associated with diagnosing sepsis and describe new approaches with technologies that harness the host’s immune response to infection. He will illustrate how these new technologies can provide a more prompt and precise assessment of the suspected sepsis patient and guide the physician in care management decisions. He will also review how a Quality Improvement (QI) initiative can provide a mechanism to evaluate and introduce these new technologies to a hospital sepsis program.
This webinar was originally recorded on 10/12/22.
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges the support provided for this webinar by Immunexpress.
Kenneth E. Remy, MD, MHSc, MSCI, FCCM
Associate Professor of Medicine, Pediatrics, Biochemistry, and Pathology, Host Immune Response-Remy Laboratory
Kenneth E. Remy, MD, MHSc, MSCI, FCCM, is a clinical associate professor at Case Western Research University in the departments of internal medicine, pediatrics, pathology, and biochemistry in the divisions of pulmonary critical care medicine and pediatric critical care medicine. He serves as the Director of the division of pulmonary critical care medicine basic science and translational critical care research and a Co-Director for clinical, basic science, and translational critical care research in the division of pediatric critical care medicine. He is also a fellow in the American College of Critical Care Medicine and fellow in the Society of Pediatric Research.
Dr. Remy is an international expert in adult and pediatric sepsis, COVID disease, and global health. He sits on a number of national and international task forces in sepsis and COVID including the NIH, BARDA, FDA and CDC. His research interests are in host inflammation in both adults and children with sepsis and how red blood cell transfusions further cause immune modulation in patients with inflammatory states. Dr. Remy has authored over 75 peer reviewed manuscripts, textbook chapters, and invited commentaries. He is the chair of the basic and translational science research section for the society of critical care medicine (SCCM) and the immunology chair for the pediatric acute lung injury and sepsis investigators blood network.
Dr. Remy has been featured on a number of news programs including CNN, CBS Evening News, BBC News, People Magazine, NBC News, Reuters, USA today, and many other local and international news stations on his experiences during this pandemic. He regularly speaks on the immunologic consequences of disease, pediatric multisystem inflammatory syndrome (MIS-C), public health measures and schools, and potential therapies for SARS-CoV-2 infection.
No continuing education credits are offered for the Sponsor Innovation Webinar.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.